CHU Paul Brousse
Villejuif, 94800, France
NCT Number: NCT05744102
The main objective of the research is to compare by two blind evaluators new MRI techniques with routinely used sequences.
Trial opening soon.
Get Notified18 year–99 year
All sexes
Interventional
Not applicable
Villejuif, 94800, France
"The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence.
The decision criterion for considering a new sequence as superior to the standard sequence will be based on two measures:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MRI sequences
Time frame: 7 years
The main evaluation criterion will be the choice of the two (or three) evaluators as to the best sequence between the new sequence and the standard sequence.
Time frame: 7 years
Average acquisition time
Time frame: 7 years
Proportion of patients for whom apnea was requested.
Contact information is provided by the study sponsor or research team.
Jean-manuel DA-MOTA-FERREIRA, Radiologic Technologist
CONTACT
Maïté LEWIN, MD, PHD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Evaluation of Advanced and New MRI Techniques to Improve Patient Diagnosis
Acronym: DIAGIRM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.